Collaborative Advancements in Genetic Medicine: UT Southwestern and Pfizer Join Forces

Daniel Siegwart, PhD

UT Southwestern Medical Center and Pfizer Inc. have embarked on a collaborative endeavor led by Principal Investigator Daniel Siegwart, PhD, to propel the field of genetic medicine forward. This partnership seeks to harness the combined expertise of both institutions, leveraging transformative contributions in chemistry, engineering, and artificial intelligence methodologies.

With a focus on advancing genetic medicine therapies, the collaboration aims to develop innovative RNA-enhanced delivery technologies. Through this concerted effort, UT Southwestern and Pfizer endeavor to expand the frontier of medical research, ultimately paving the way for the development of novel therapies that hold the potential to transform patient care and treatment outcomes.